The stock has room to rebound even further, and is a buy at these levels.
Omada Health, Inc. (OMDA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Sionna Therapeutics, Inc. (SION) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Upstream Bio, Inc. (UPB) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Cheniere's scale and >95% contract coverage beat Venture Global's faster buildout and cheaper valuation in a close LNG showdown.
Lands' End, Inc. reported very weak Q1 results due to transitory operational disruption. The hiccup isn't cause for worry but limits Q1 results' signaling value. Q1 disclosures gave much better insight into LE's joint venture with WHP Global. The partnership has clear pros and cons. LE established an FY2026 guidance and guides improved sales momentum but thinner margins due to royalty payments.
Abacus Global Management (NYSE:ABX) has unveiled LifeARC, a proprietary AI-powered platform that generates personalized lifespan models for individuals using medical history, medications, genetics, and biometrics. The alternative asset manager said LifeARC draws on 20 years of proprietary data to produce individualized longevity projections.
Designed to provide broad exposure to the Small Cap Blend segment of the US equity market, the Global X Russell 2000 ETF (RSSL) is a passively managed exchange traded fund launched on June 4, 2024.
Develop Global Limited (VTEXF) Discusses Final Investment Decisions, USD 400 Million Funding Facility, and Trafigura Collaboration Transcript
Zealand Pharma A/S (ZLDPY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Medline Inc. (MDLN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Palvella Therapeutics, Inc. (PVLA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript